| |
Abstract |
| Title |
: Cost-effectiveness after modified pharmaceutical care process in Diabetes clinic at Warinchamrab hospital |
| By |
: Punyawee Teptewasan and Sutthipat Panrat |
| Degree |
: DOCTOR OF PHILOSOPHY |
| Major |
: HEALTH SERVICE MANAGEMENT |
| Advisor |
: Thanatcha Songmuang, Ananya Songmuang, Saksit Sripa and Jeerisuda Khumsikiew |
| Keywords |
: Pharmaceutical Care, Cost-Effectiveness, Cost, Effectiveness of Diabetes Care |
| |
|
| Since year 2015, the modified pharmaceutical care process which is proactive pharmaceutical care in individual patients has been implemented in diabetic clinic of Warinchamrab hospital. In pilot study, the clinical outcomes have been improved but not known about their cost. Objectives: To estimate the cost effectiveness after modified pharmaceutical care process Methods: This study was retrospective study based on hospital electronic database. The cost and effectiveness have been explored in health care provider perspective and compared between year 2014 and year 2015. McNemar test and Wilcoxon signed-rank test was used for statistical testing in categorical data and continuous data. Results: After modified process of pharmaceutical care found that total cost per person per year was increased in statistical significance (p<0.05) in most variables. On the contrary, there were statistically significant reduction of total cost per person per year in patients with proteinuria <300 mg/day (microalbuminuria), achieved average FBS target (70 - 130 mg/dL) and admitted to hospital to hospital from hypoglycemia. In effectiveness, There were statistically significant improvements (p<0.05) including mean FBS, proteinuria, being admitted to hospital to hospital from hyperglycemia. The incremental cost-effectiveness ratio (ICER) of two variables including patients who have achieved mean FBS target and microalbuminuria were dominant which indicates that there were better health outcomes at lower costs after modified pharmaceutical care process. Conclusion: Proactive pharmaceutical care in diabetes clinic, in which the pharmacist spent more time providing personalized care can improved glycemic control. Moreover, there were cost effective in patients who have achieved mean FBS target and microalbuminuria. |
| |
|
| Close this window |